Microbot Medical Inc. (MBOT) Fair Value 2026

MBOT · Surgical & Medical Instruments & Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.0 /10

32 fundamental signals · 8 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-07-15, Microbot Medical Inc. (MBOT) trades at $1.86, approximately 258% above CirclFi’s Bayesian DCF fair value of $0.52. QOC: 5.0/10. Value Trap Risk: 24/100 (SAFE). 8/13 models active.

Key Facts

Ticker
MBOT
Price
$1.86
Quality Score
5.0/10
Value Trap Risk
24/100
Models Active
8/13
Last Updated
Strength: First Chicago suggests +3.9% upside with 15% confidence
Risk: Majority of models suggest overvaluation

Is Microbot Medical Inc. (MBOT) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, Microbot Medical Inc. (MBOT) appears overvalued as of : the median of 8 independent fair value estimates is $1.20, 35.3% below the current price of $1.86. Estimates range from $0.05 to $2.24. MBOT scores 5.0/10 on fundamental quality and 24/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Microbot Medical Inc. Stock in 2026? →

Valuation Matrix

8 Intrinsic Value Models vs. Current Price ($1.86)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $0.52 -72.1%
CUCE Ensemble
Low Conviction
 $1.08 -41.7%
First Chicago
Low Conviction
 $1.93 +3.9%
Dynamic NAV
High Conviction
 $1.32 -28.9%

Unlock the Full Matrix

Access 4 additional models including ML-RIV, PWERM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is Microbot Medical Inc. (MBOT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Microbot Medical Inc.'s intrinsic value is estimated at a composite fair value of $1.17. Trading at $1.86, the stock is approaching fair value or slight overvaluation (implied return of -37.0%), as 5 of 8 models suggest limited further upside. The most optimistic model, Sentiment SOTP, places fair value at $2.24 (+20.6%), while Regime Cross — the most conservative — estimates $0.05 (-97.6%). This +118.2% gap reflects genuine analytical uncertainty about Microbot Medical Inc.'s intrinsic worth.

What Do the Models Say About MBOT?

8 of 13 models are currently active for MBOT. Of these, 2 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates MBOT's intrinsic value at $0.52, implying -72.1% downside from the current price. See which stocks rank higher →

How Does MBOT Rank in Surgical & Medical Instruments & Apparatus?

Among 109 Surgical & Medical Instruments & Apparatus stocks, MBOT ranks #86 by Quality of Company score. CirclFi's QOC score of 5.0/10 evaluates 32 fundamental signals. A score of 5.0 reflects mixed fundamentals.

See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →

Microbot Medical Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is MBOT a Value Trap?

CirclFi's Value Trap algorithm assigns MBOT a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for Microbot Medical Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Microbot Medical Inc. scores 5.0 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +118.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MBOT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MBOT's 8 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Microbot Medical Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Surgical & Medical Instruments & Apparatus Stocks Should You Also Analyze?

8 related Surgical & Medical Instruments & Apparatus stocks with 13-model coverage

DXCMDexCom, Inc.QOC 10.0IRMDiRadimed CorporationQOC 10.0PODDInsulet CorporationQOC 10.0RMDResMed Inc.QOC 10.0WSTWest Pharmaceutical Services, IQOC 9.9HAEHaemonetics CorporationQOC 9.8LMATLeMaitre Vascular, Inc.QOC 9.8GMEDGlobus Medical, Inc.QOC 9.2

Read investment analysis: DXCM · IRMD · PODD · RMD · WST

See all Surgical & Medical Instruments & Apparatus stocks ranked →

Frequently Asked Questions About Microbot Medical Inc.

What is Microbot Medical Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Microbot Medical Inc. (MBOT) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.52. The Quality of Company score is 5.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MBOT overvalued or undervalued right now?

At $1.86, 2 of 8 active models suggest MBOT may be undervalued, while 6 indicate potential overvaluation. The median of all 8 fair value estimates is $1.20, 35.3% below the current price of $1.86 — a consensus view that MBOT is overvalued. The assessment depends on which methodology best fits Microbot Medical Inc.'s business model in Surgical & Medical Instruments & Apparatus.

What does a Quality of Company score of 5.0 mean for MBOT?

Microbot Medical Inc.'s QOC of 5.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on MBOT?

CirclFi analyzes MBOT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Is MBOT a value trap in 2026?

Microbot Medical Inc.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 8-model valuation engine, Microbot Medical Inc. (MBOT) has a median fair value of $1.20 — 35.3% below the current price of $1.86 — as of 2026-07-15.” Source: circlfi.com/stock/MBOT/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on MBOT.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access